Integrative Bone Metabolomics—Lipidomics Strategy for Pathological Mechanism of Postmenopausal Osteoporosis Mouse Model

Abstract Osteoporosis, characterized by bone mass reduction and increased fractures, has become a global health problem that seriously affects the health of people, especially postmenopausal women; however, the current pathogenesis of postmenopausal osteoporosis (PMOP) has not been thoroughly elucid...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hongxia Zhao, Xiaoqun Li, Dianying Zhang, Haiyan Chen, Yufan Chao, Kaiwen Wu, Xin Dong, Jiacan Su
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/1897ce3a0b6f4955bd4551d6495da09f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1897ce3a0b6f4955bd4551d6495da09f
record_format dspace
spelling oai:doaj.org-article:1897ce3a0b6f4955bd4551d6495da09f2021-12-02T15:08:57ZIntegrative Bone Metabolomics—Lipidomics Strategy for Pathological Mechanism of Postmenopausal Osteoporosis Mouse Model10.1038/s41598-018-34574-62045-2322https://doaj.org/article/1897ce3a0b6f4955bd4551d6495da09f2018-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-34574-6https://doaj.org/toc/2045-2322Abstract Osteoporosis, characterized by bone mass reduction and increased fractures, has become a global health problem that seriously affects the health of people, especially postmenopausal women; however, the current pathogenesis of postmenopausal osteoporosis (PMOP) has not been thoroughly elucidated to date. In this study, bilateral ovariectomy was performed to establish an OVX mouse model of osteoporosis. UPLC-Q-TOF-MS-based lipidomics in combination with metabolomics were used to analyze the femur tissue of osteoporosis mice. We found that 11 polar metabolites and 93 lipid metabolites were significantly changed and were involved in amino acid metabolism, nucleotide metabolism and lipid metabolism. Among the lipids, fatty acyls, glycerolipids, glycerophospholipids, sphingolipids and sterols showed robust changes. These results revealed that several metabolic disorders caused by changes in the hormone levels in OVX, especially disordered lipid metabolism, are closely related to the imbalance between bone resorption and formation and may underlie the development of PMOP. The data generated via lipidomics and metabolomics presented in this study shows good applicability and wide coverage in the construction of the metabolic profile of bone tissue. Therefore, this approach may provide the pathway focusing and data support at the metabolite level for the in-depth mechanism of PMOP.Hongxia ZhaoXiaoqun LiDianying ZhangHaiyan ChenYufan ChaoKaiwen WuXin DongJiacan SuNature PortfolioarticleOsteoporosis MicePostmenopausal OsteoporosisGlycerophospholipidsBone Volume/total Volume (BV/TV)Lipidomic AnalysisMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-11 (2018)
institution DOAJ
collection DOAJ
language EN
topic Osteoporosis Mice
Postmenopausal Osteoporosis
Glycerophospholipids
Bone Volume/total Volume (BV/TV)
Lipidomic Analysis
Medicine
R
Science
Q
spellingShingle Osteoporosis Mice
Postmenopausal Osteoporosis
Glycerophospholipids
Bone Volume/total Volume (BV/TV)
Lipidomic Analysis
Medicine
R
Science
Q
Hongxia Zhao
Xiaoqun Li
Dianying Zhang
Haiyan Chen
Yufan Chao
Kaiwen Wu
Xin Dong
Jiacan Su
Integrative Bone Metabolomics—Lipidomics Strategy for Pathological Mechanism of Postmenopausal Osteoporosis Mouse Model
description Abstract Osteoporosis, characterized by bone mass reduction and increased fractures, has become a global health problem that seriously affects the health of people, especially postmenopausal women; however, the current pathogenesis of postmenopausal osteoporosis (PMOP) has not been thoroughly elucidated to date. In this study, bilateral ovariectomy was performed to establish an OVX mouse model of osteoporosis. UPLC-Q-TOF-MS-based lipidomics in combination with metabolomics were used to analyze the femur tissue of osteoporosis mice. We found that 11 polar metabolites and 93 lipid metabolites were significantly changed and were involved in amino acid metabolism, nucleotide metabolism and lipid metabolism. Among the lipids, fatty acyls, glycerolipids, glycerophospholipids, sphingolipids and sterols showed robust changes. These results revealed that several metabolic disorders caused by changes in the hormone levels in OVX, especially disordered lipid metabolism, are closely related to the imbalance between bone resorption and formation and may underlie the development of PMOP. The data generated via lipidomics and metabolomics presented in this study shows good applicability and wide coverage in the construction of the metabolic profile of bone tissue. Therefore, this approach may provide the pathway focusing and data support at the metabolite level for the in-depth mechanism of PMOP.
format article
author Hongxia Zhao
Xiaoqun Li
Dianying Zhang
Haiyan Chen
Yufan Chao
Kaiwen Wu
Xin Dong
Jiacan Su
author_facet Hongxia Zhao
Xiaoqun Li
Dianying Zhang
Haiyan Chen
Yufan Chao
Kaiwen Wu
Xin Dong
Jiacan Su
author_sort Hongxia Zhao
title Integrative Bone Metabolomics—Lipidomics Strategy for Pathological Mechanism of Postmenopausal Osteoporosis Mouse Model
title_short Integrative Bone Metabolomics—Lipidomics Strategy for Pathological Mechanism of Postmenopausal Osteoporosis Mouse Model
title_full Integrative Bone Metabolomics—Lipidomics Strategy for Pathological Mechanism of Postmenopausal Osteoporosis Mouse Model
title_fullStr Integrative Bone Metabolomics—Lipidomics Strategy for Pathological Mechanism of Postmenopausal Osteoporosis Mouse Model
title_full_unstemmed Integrative Bone Metabolomics—Lipidomics Strategy for Pathological Mechanism of Postmenopausal Osteoporosis Mouse Model
title_sort integrative bone metabolomics—lipidomics strategy for pathological mechanism of postmenopausal osteoporosis mouse model
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/1897ce3a0b6f4955bd4551d6495da09f
work_keys_str_mv AT hongxiazhao integrativebonemetabolomicslipidomicsstrategyforpathologicalmechanismofpostmenopausalosteoporosismousemodel
AT xiaoqunli integrativebonemetabolomicslipidomicsstrategyforpathologicalmechanismofpostmenopausalosteoporosismousemodel
AT dianyingzhang integrativebonemetabolomicslipidomicsstrategyforpathologicalmechanismofpostmenopausalosteoporosismousemodel
AT haiyanchen integrativebonemetabolomicslipidomicsstrategyforpathologicalmechanismofpostmenopausalosteoporosismousemodel
AT yufanchao integrativebonemetabolomicslipidomicsstrategyforpathologicalmechanismofpostmenopausalosteoporosismousemodel
AT kaiwenwu integrativebonemetabolomicslipidomicsstrategyforpathologicalmechanismofpostmenopausalosteoporosismousemodel
AT xindong integrativebonemetabolomicslipidomicsstrategyforpathologicalmechanismofpostmenopausalosteoporosismousemodel
AT jiacansu integrativebonemetabolomicslipidomicsstrategyforpathologicalmechanismofpostmenopausalosteoporosismousemodel
_version_ 1718387923093553152